Mind Medicine (MNMD) Tops Q3 EPS by 20c

Mind Medicine (NASDAQ: MNMD) reported Q3 EPS of ($0.45), $0.20 better than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Mind Medicine (MNMD) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• UBS Reiterates Buy Rating on Linde (LIN) as Challenges in Helium Are 'Being Managed'
• Broadcom Limited (AVGO) PT Lowered to $350 at DA Davidson